(Q38572827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

22 February 2020

main subject

0 references

0 references

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Julian Panes

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Richard Gearry

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Peter Laszlo Lakatos

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Edward V Loftus

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ingrid Ordas

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Benjamin Pariente

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jean-Frederic Colombel

38

object named as

J-F Colombel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

L Peyrin-Biroulet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

B E Sands

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

W Reinisch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

W Bemelman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

R V Bryant

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

G D'Haens

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

I Dotan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Dubinsky

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Krishnareddy

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

P Marteau

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

P Munkholm

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

T B Murdoch

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

R Panaccione

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

R H Riddell

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

J Ruel

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

D T Rubin

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Samaan

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

C A Siegel

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M S Silverberg

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

J Stoker

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Schreiber

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Travis

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

G Van Assche

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Danese

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

G Bouguen

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S O'Donnell

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Winer

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Hanauer

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

W Sandborn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

B Feagan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

25 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1324-1338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

22 February 2020

cites work

1 reference

12 December 2020

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

1 reference

12 December 2020

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis

1 reference

12 December 2020

Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study.

1 reference

12 December 2020

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

12 December 2020

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

1 reference

12 December 2020

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

1 reference

12 December 2020

Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity

1 reference

12 December 2020

Mucosal healing in inflammatory bowel diseases: a systematic review

1 reference

12 December 2020

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

1 reference

12 December 2020

Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register

1 reference

12 December 2020

IBD and health-related quality of life -- discovering the true impact.

1 reference

12 December 2020

Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review

1 reference

12 December 2020

Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease

1 reference

12 December 2020

Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts.

1 reference

12 December 2020

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years

1 reference

12 December 2020

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE.

1 reference

12 December 2020

Mucosal healing in Crohn's disease: a systematic review

1 reference

12 December 2020

The depression status inventory: An adjunct to the self-rating depression scale

1 reference

12 December 2020

Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales

1 reference

12 December 2020

Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets

1 reference

12 December 2020

Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

1 reference

12 December 2020

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices

1 reference

12 December 2020

Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence

1 reference

12 December 2020

Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis

1 reference

12 December 2020

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

1 reference

12 December 2020

Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort

1 reference

12 December 2020

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin

1 reference

12 December 2020

Vedolizumab as induction and maintenance therapy for ulcerative colitis

1 reference

12 December 2020

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

12 December 2020

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

12 December 2020

Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease.

1 reference

12 December 2020

The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence

1 reference

12 December 2020

Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings

1 reference

12 December 2020

Adalimumab induces deep remission in patients with Crohn's disease.

1 reference

12 December 2020

Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors.

1 reference

12 December 2020

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

12 December 2020

Mucosal biopsy of the rectum, colon, and distal ileum

1 reference

12 December 2020

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

1 reference

12 December 2020

Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis

1 reference

12 December 2020

Review article: Description and management of fatigue in inflammatory bowel disease

1 reference

12 December 2020

Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy

1 reference

12 December 2020

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

1 reference

12 December 2020

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

1 reference

12 December 2020

Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies

1 reference

12 December 2020

The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

1 reference

12 December 2020

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

1 reference

12 December 2020

Infliximab, azathioprine, or combination therapy for Crohn's disease

1 reference

12 December 2020

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

1 reference

12 December 2020

Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease

1 reference

12 December 2020

How fatigue is experienced and handled by female outpatients with inflammatory bowel disease

1 reference

12 December 2020

The influence of depression on quality of life in patients with inflammatory bowel disease

1 reference

12 December 2020

The natural history of adult Crohn's disease in population-based cohorts

1 reference

12 December 2020

Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis

1 reference

12 December 2020

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

The rating form of IBD patient concerns: a new measure of health status

1 reference

12 December 2020

The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial

1 reference

12 December 2020

Treat to target: a proposed new paradigm for the management of Crohn's disease

1 reference

12 December 2020

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

12 December 2020

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

1 reference

12 December 2020

Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort

1 reference

12 December 2020

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.

1 reference

12 December 2020

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

12 December 2020

The hospital anxiety and depression scale

1 reference

12 December 2020

Quality of life in inflammatory bowel disease.

1 reference

12 December 2020

The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease

1 reference

12 December 2020

Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures

1 reference

12 December 2020

Severe ulcerative colitis: prospective study of parameters determining outcome

1 reference

12 December 2020

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

12 December 2020

Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts

1 reference

12 December 2020

Development of the Crohn's disease digestive damage score, the Lémann score

1 reference

12 December 2020

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

1 reference

12 December 2020

Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease.

1 reference

12 December 2020

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial.

1 reference

12 December 2020

The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis

1 reference

12 December 2020

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

12 December 2020

A simple clinical colitis activity index

1 reference

12 December 2020

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

1 reference

12 December 2020

Risk factors of anxiety and depression in inflammatory bowel disease.

1 reference

12 December 2020

Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

1 reference

12 December 2020

Ulcerative colitis as a progressive disease: the forgotten evidence

1 reference

12 December 2020

Crohn's disease, fatigue, and infliximab: is there a role for cytokines in the pathogenesis of fatigue?

1 reference

12 December 2020

An Inventory for Measuring Depression

1 reference

12 December 2020

Crohn's disease management after intestinal resection: a randomised trial.

1 reference

12 December 2020

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

1 reference

12 December 2020

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.

1 reference

12 December 2020

Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn's disease

1 reference

12 December 2020

A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis

1 reference

12 December 2020

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

1 reference

12 December 2020

Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse

1 reference

12 December 2020

Histologic remission: the ultimate therapeutic goal in ulcerative colitis?

1 reference

12 December 2020

Certolizumab pegol for the treatment of Crohn's disease

1 reference

12 December 2020

Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.

1 reference

12 December 2020

Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease

1 reference

12 December 2020

Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management

1 reference

12 December 2020

Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis

1 reference

12 December 2020

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

1 reference

12 December 2020

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial

1 reference

12 December 2020

Development and validation of a pediatric Crohn's disease activity index

1 reference

12 December 2020

Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis

1 reference

12 December 2020

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

1 reference

12 December 2020

C-reactive protein: a critical update

1 reference

12 December 2020

Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis

1 reference

12 December 2020

Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease

1 reference

12 December 2020

European consensus on the histopathology of inflammatory bowel disease.

1 reference

12 December 2020

Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity

1 reference

12 December 2020

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

1 reference

12 December 2020

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

1 reference

12 December 2020

Microscopic activity in ulcerative colitis: what does it mean?

1 reference

12 December 2020

Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis.

1 reference

12 December 2020

Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis

1 reference

12 December 2020

Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease

1 reference

12 December 2020

Clinically active Crohn's disease in the presence of a low C-reactive protein

1 reference

12 December 2020

Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

1 reference

12 December 2020

C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I

1 reference

12 December 2020

A comparison of the discriminatory power of the Inflammatory Bowel Disease Questionnaire and the SF-36 in people with ulcerative colitis.

1 reference

12 December 2020

Hospitalisations and surgery in Crohn's disease

1 reference

12 December 2020

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

1 reference

12 December 2020

Converging goals of treatment of inflammatory bowel disease from clinical trials and practice

1 reference

12 December 2020

1 reference

12 December 2020

Biomarkers of inflammatory bowel disease

1 reference

12 December 2020

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

1 reference

12 December 2020

Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.

1 reference

12 December 2020

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

1 reference

12 December 2020

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?

1 reference

12 December 2020

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

1 reference

12 December 2020

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process

1 reference

12 December 2020

Infliximab improves quality of life in patients with Crohn's disease

1 reference

12 December 2020

Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity

1 reference

12 December 2020

Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.

1 reference

12 December 2020

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

1 reference

12 December 2020

Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study

1 reference

12 December 2020

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

1 reference

12 December 2020

Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.

1 reference

12 December 2020

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

1 reference

12 December 2020

Determinants of fatigue in Crohn's disease patients.

1 reference

12 December 2020

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

1 reference

12 December 2020

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

1 reference

12 December 2020

Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease

1 reference

12 December 2020

Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study

1 reference

12 December 2020

Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.

1 reference

12 December 2020

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis

1 reference

12 December 2020

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

1 reference

12 December 2020

Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists

1 reference

12 December 2020

Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response

1 reference

12 December 2020

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.

1 reference

12 December 2020

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

1 reference

12 December 2020

Increased risks of developing anxiety and depression in young patients with Crohn's disease.

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative

1 reference

12 December 2020

The histopathological approach to inflammatory bowel disease: a practice guide

1 reference

12 December 2020

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

1 reference

12 December 2020

Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.

1 reference

12 December 2020

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

12 December 2020

A simple index of Crohn's-disease activity

1 reference

12 December 2020

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis

1 reference

12 December 2020

European evidence based consensus for endoscopy in inflammatory bowel disease

1 reference

12 December 2020

Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.

1 reference

12 December 2020

A new measure of health status for clinical trials in inflammatory bowel disease

1 reference

12 December 2020

Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease

1 reference

12 December 2020

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

1 reference

12 December 2020

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

1 reference

12 December 2020

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2015.233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26303131%20AND%20SRC:MED&resulttype=core&format=json